BEIJING, Dec. 9, 2024
/PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord
Medical" or the "Company") (NYSE: CCM), a healthcare provider
specialized in cancer treatment, research, education and prevention
in China, today announced that the
National Medical Products Administration of the People's Republic of China has granted
approval to the application for the Registration Certificate for
Medical Device for the proton therapy equipment (the "Registration
Certificate") made by the Company's equipment supplier on
December 6, 2024.
As previously disclosed in the Company's annual report for the
fiscal year ended December 31, 2023,
Guangzhou Concord Cancer Center ("Guangzhou Hospital"), a PRC
subsidiary of the Company offering comprehensive cancer care
services, has completed the installment of the proton equipment in
September 2020 and commenced its
clinical trial in November 2022.
Guangzhou Hospital has also subsequently obtained the large medical
equipment procurement license for its proton equipment in
September 2024. Upon obtaining the
approval for the Registration Certificate, Guangzhou Hospital
plans to start its proton therapy treatment services at its
earliest convenience after necessary preparations.
Concord Healthcare Group Co., Ltd. ("Concord Healthcare"),
a subsidiary of the Company listed on the Main Board of The Stock
Exchange of Hong Kong Limited (the "HKSE") under the stock code
2453.HK, also announced on December 9,
2024 that the approval for Registration Certificate was
granted. The Company previously announced the listing of Concord
Healthcare's H shares on the HKSE on January 9, 2024. The
information related to Concord Healthcare's Transactions on the
HKSE is accessible through the HKSE's website
at www.hkexnews.hk.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider featuring a full cycle of premium oncology services
including cancer diagnosis, treatment, education and prevention.
The Company focuses on providing multidisciplinary cancer care in
all aspects of oncology healthcare services in its cancer hospitals
and equipping them with technologically advanced equipment such as
the state-of-the-art proton therapy system. The Company is striving
to improve the quality and accessibility of cancer care through its
network of self-owned cancer hospitals and clinics as well as
partnered hospitals across China.
For more information, please see http://ir.ccm.cn.
About Concord Healthcare
Concord Healthcare is an oncology healthcare provider in
China. Concord Healthcare serves
both cancer patients through self-owned medical institutions and
third-party medical institutions through medical equipment,
software and related services. In its self-owned medical
institutions, Concord Healthcare provides a full spectrum of
oncology healthcare services to cancer patients across the entire
care continuum, leveraging its multidisciplinary team specialists
and diagnosis and treatment capabilities featuring precision
radiation therapy. Through its medical equipment, software and
related services, Concord Healthcare serves a widespread network of
enterprise customers, primarily hospitals, with integrated
oncology-related services, including primarily sales and
installing of medical equipment and software, management and
technical support, and operating lease.
Safe Harbor Statement
This announcement contains forward-looking statements. These
forward-looking statements can be identified by words or phrases
such as "will," "expects," "anticipates," "future," "intends,"
"plans," "believes," "estimates" and similar expressions.
Forward-looking statements are inherently subject to uncertainties
and contingencies beyond the Company's control and based upon
premises with respect to future business decisions, which are
subject to change. A number of important factors could cause actual
results to differ materially from those contained in any
forward-looking statement. The Company does not undertake any
obligation to update any forward-looking statement, except as
required under applicable law.
View original
content:https://www.prnewswire.com/news-releases/concord-healthcare-announces-approval-granted-to-the-application-for-the-proton-therapy-equipment-registration-certificate-302326028.html
SOURCE Concord Medical Services Holdings Limited